Stocks & Investing
Thu, June 24, 2021
[ 12:00 AM ] - WOPRAI
Wed, February 20, 2019
Thu, April 13, 2017
Tue, January 17, 2017
Tue, November 29, 2016
Mon, April 27, 2015
Tue, April 21, 2015
Tue, July 8, 2014 Leah Cann Initiated (CCCC) at Strong Buy and Held Target at $54 on, Jun 24th, 2021
Leah Cann of Brookline Capital, Initiated "C4 Therapeutics, Inc." (CCCC) at Strong Buy and Held Target at $54 on, Jun 24th, 2021.
Leah has made no other calls on CCCC in the last 4 months.
There are 2 other peers that have a rating on CCCC. Out of the 2 peers that are also analyzing CCCC, 0 agree with Leah's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Leah
- Andrew Fein of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $63 on, Friday, June 4th, 2021
- Matthew Luchini of "BMO Capital" Initiated at Buy and Held Target at $55 on, Wednesday, March 31st, 2021
